Abortion Debate Adds To Difficulty Of Returning To Drug Pricing Legislation

By John Wilkerson / May 9, 2022 at 4:49 PM
The debate over abortion will dominate Congress this week and possibly into midterm elections, which lobbyists say will further scramble Democrats’ agenda and take away time the party might have spent on budget reconciliation and the government drug price controls that package would almost surely contain. The budget reconciliation bill has been on the back burner for about half a year since Sen. Joe Manchin (D-WV) scuttled what was then called Build Back Better. Democrats continue to talk about wanting...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.